Phase II trial of 4'-epi-doxorubicin in metastatic melanoma.
D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000633:toxicity*; D004317:Doxorubicin / Q000627:therapeutic use / Q000633:toxicity*; D004341:Drug Evaluation; D015251:Epirubicin; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D013237:Stereoisomerism
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin; D004317:Doxorubicin